Le Lézard
Classified in: Transportation, Health, Business
Subjects: PDT, OTC

Priority Aviation Announces Telluride Health Company Product Reveal Targeting $30 Billion Marijuana Market Opportunity Schedule Wednesday Next Week


NEW YORK, October 26, 2017 /PRNewswire/ --

Telluride Health Company, a subsidiary of Priority Aviation Inc. (OTC PINK: PJET), today updated its previously released plans for a product reveal scheduled next week, on Wednesday, November 1, 2017. In addition to revealing the first product for an untapped sector of the overall marijuana market that Forbes magazine has predicted will be a $30 billion market by 2021, Telluride Health Company will also address recent shareholder questions regarding overall corporate plans to include changing the Priority Aviation name, changing the ticker symbol, maintaining the existing capitalization structure and reducing legacy debt.

Look for more information on the company's new product and direction as Telluride Health Company coming soon.

Website: http://www.telluridehealthcompany.com

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward-looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward- looking statements as a result of a wide range of factors.

Priority Aviation, Inc.
Yasmine Acebo
CEO 
Phone: THC phone # 1-800-852-0426
Email: [email protected]

SOURCE Priority Aviation Inc.


These press releases may also interest you

at 23:30
Remidio Inc., a health technology innovator developing cutting-edge technology to combat global blindness from Diabetic Retinopathy, Glaucoma, AMD, & Cataracts, is all set to achieve a significant milestone....

at 22:30
Information Mediary Corp (IMC) and Adherence have collaborated to introduce a digitized Morisky Medication Adherence Scale (MMAS), revolutionizing medication adherence management. This innovative solution signifies a significant advancement in...

at 22:15
Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced the pricing of a public offering of 804,999 shares...

at 20:20
Planned Parenthood of Metropolitan Washington, DC (PPMW) recently received an Underserved Communities Projects grant from Montgomery County, Maryland, to grow the PPMW Promotoras de Salud community health outreach program. The Promotoras de Salud...

at 20:06
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 20:00
Adcentrx Therapeutics ("Adcentrx"), a biotechnology company revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other life-threatening diseases, announced today that China National Medical Products Administration (NMPA) has...



News published on and distributed by: